Interleukin-6 and Mycoplasma hominis as markers of preterm birth and related brain damage: Our experience. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians [J Matern Fetal Neonatal Med] Journal article

Title	Interleukin-6 and Mycoplasma hominis as markers of preterm birth and related brain damage: Our experience.
Author(s)	Massaro G, Scaravilli G, Simeone S, Capuano S, Pastore E, Forte A, Parisi P, Ferraiolo A, Costanzo A, Balbi C
Institution	Department of Obstetrics and Gynecology, Second University of Naples, Caserta, Italy.
Source	J Matern Fetal Neonatal Med 2009 Jun 24.:1-5.
Abstract	Objective. The aim of this study is to investigate whether a high concentration of interleukin-6 (IL)-6 in the amniotic fluid is associated to a higher risk of preterm delivery, premature rupture of the membranes (PROM), and periventricular leucomalacia (PVL) in preterm infants; we have further investigated whether the levels of IL-6 are related to the presence of vaginal infection by mycoplasms. Methods. One hundred eight patients were screened by vaginal swab, sonography, amniocentesis, and dosage of IL-6 in the amniotic fluid during the second trimester of pregnancy. Results. High levels of IL-6 and vaginal mycoplasms are related to preterm birth and PROM. We had no case of PLV. Conclusion. In order to achieve a good therapeutic purpose and get to an efficient strategy, the patients have to be elected by a number of criteria, which may include anamnesis elements, vaginal swab, then cytokines dosage in selected women, thus excluding the low-risk cases. Further studies are expected in order to plan guidelines including the dosage of ILs and principally of IL-6 as a main marker of preterm birth, above all during the second trimester.
Language	ENG
Pub Type(s)	JOURNAL ARTICLE
PubMed ID	19557661

Advertise on this site.